Advised a consortium comprised of China Resources, one of China’s largest state-owned enterprises, and Macquarie Capital, on its acquisition of the majority interest in GenesisCare Limited and associated shareholders’ agreement and management incentive plan. Corrs also advised Macquarie Capital on its subsequent exit from GenesisCare and sale of its interests to funds advised by KKR. GenesisCare is Australia's largest provider of radiation oncology, cardiology and sleep treatments with operations in the United Kingdom and Spain.